Effect of eggplant (Solanum melongena) on the metabolic syndrome: A review

Yarmohammadi, F., Ghasemzadeh Rahbardar, M., Hosseinzadeh, H · Iranian Journal of Basic Medical Sciences · 2021 January

DOI 10.22038/ijbms.2021.50276.11452

Objective

Metabolic syndrome reduction with eggplant

Conclusions

The study concluded that eggplant has efficacy with controlling diabetes through the anti-oxidative properties and inhibition of α-amylase and α-glucosidase activity. It also helps with protective effects on hyperlipidemia and obesity.

Critical Appraisal

Published research can offer valuable insights, but a paper’s conclusions may go beyond what its results support. Critical appraisal examines the methods, findings and limitations to clarify what can reasonably be concluded—and what remains uncertain.

This article has not yet been critically appraised by the Research Hub.

Learn more about Critical Appraisal

Insights

Eggplant can be useful in the treatment of metabolic syndrome and its complications.

Eggplant (Solanum melongena) is a rich source of phenolic and alkaloid compounds. It possesses various pharmacological effects, including, anti-oxidant, antidiabetic, antihypertensive, and antihyperlipidemic, which has been supported by numerous investigations. In this review, we evaluated the effects of eggplant on metabolic syndrome and its complications comprising diabetes, high blood pressure, hyperlipidemia, and obesity. According to these studies, eggplant can control diabetes through the anti-oxidative properties and inhibition of α-amylase and α-glucosidase activity. Also, eggplant has exerted an antihypertensive effect via ACE inhibitory activity. Eggplant may have shown protective effects on hyperlipidemia and obesity via the induction of lipoprotein lipase activity and the reduction of pancreatic lipase activity. Eggplant can be useful in the treatment of MetS and its complications.